Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00985998
Recruitment Status : Withdrawn (no paticipants enrolled)
First Posted : September 29, 2009
Last Update Posted : August 19, 2015
Information provided by (Responsible Party):
Biotech Pharmaceutical Co., Ltd.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : August 2015
  Study Completion Date : August 2015